臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 141-190 / 1137 (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-06-10T06:11:00Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏	2022-06-10T06:10:58Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; ZHONG-ZHE LIN; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-06-10T06:10:57Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients	Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-06-10T06:10:55Z	Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; ZHONG-ZHE LIN; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-06-10T06:10:54Z	Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life	Hsieh C.-C.; Ho C.-C.; ZHONG-ZHE LIN; Yu C.-J.; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H.
臺大學術典藏	2022-06-10T06:10:51Z	The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients	Hsiao F.-H.; ZHONG-ZHE LIN; Huang F.-Y.; Lai Y.-M.; Chen Y.-T.; Shih J.-Y.; Ho C.-C.; Yu C.-J.; Hsieh C.-C.
臺大學術典藏	2022-04-20T07:19:23Z	Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women	Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; Shih J.-Y.; Yang P.-C.; CHUHSING KATE HSIAO; Lai L.-C.; Chuang E.Y.
臺大學術典藏	2022-04-19T08:09:29Z	Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life	Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; FEI-HSIU HSIAO
臺大學術典藏	2022-04-19T08:09:26Z	The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients	FEI-HSIU HSIAO; Lin Z.-Z.; Huang F.-Y.; Lai Y.-M.; Chen Y.-T.; Shih J.-Y.; Ho C.-C.; Yu C.-J.; Hsieh C.-C.
臺大學術典藏	2022-03-09T03:12:33Z	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; HUEI-WEN CHEN; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:52Z	Pulmonary pleomorphic (spindle) cell carcinoma: Peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma	Chang Y.-L.; Lee Y.-C.; Shih J.-Y.; CHEN-TU WU
臺大學術典藏	2022-03-04T05:33:51Z	New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas	Chang Y.-L.; CHEN-TU WU; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:50Z	Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers	Chang Y.-L.; CHEN-TU WU; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:49Z	Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers	Lee Y.-C.; CHEN-TU WU; Shih J.-Y.; Jou Y.-S.; Chang Y.-L.
臺大學術典藏	2022-03-04T05:33:48Z	The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers	CHEN-TU WU; Chang Y.-L.; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:46Z	Estrogen receptor β - Which one and where should we draw the line - Reply [2]	CHEN-TU WU; Chang Y.-L.; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:44Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-03-04T05:33:42Z	Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas	Chang Y.-L.; CHEN-TU WU; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:42Z	Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers	Chang Y.-L.; CHEN-TU WU; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:41Z	EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy	Chang Y.-L.; CHEN-TU WU; Shih J.-Y.; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:41Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Wu S.-G.; Chang Y.-L.; Lin J.-W.; CHEN-TU WU; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2022-03-04T05:33:41Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; CHEN-TU WU; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-03-04T05:33:39Z	The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction	Chang Y.-L.; Lin M.-W.; Shih J.-Y.; CHEN-TU WU; Lee Y.-C.
臺大學術典藏	2022-03-04T05:33:37Z	Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension	Lin M.-W.; CHEN-TU WU; Shih J.-Y.; Chang Y.-L.; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:28Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-03-04T05:33:27Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-23T02:19:42Z	In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry	Chen K.-C.; Yin W.-H.; CHIH-CHENG WU; Chan S.-H.; Wu Y.-W.; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G.
臺大學術典藏	2022-02-21T03:52:43Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	JIH-HSIANG LEE; Yu C.-J.; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏	2022-02-21T03:52:42Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; Yu C.-J.; JIH-HSIANG LEE; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-02-21T03:52:39Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	JIH-HSIANG LEE; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:38Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Liao B.-C.; JIH-HSIANG LEE; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:35Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:35Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:34Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients	Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:34Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.; Bai Y.-Y.; JIH-HSIANG LEE; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2022-02-21T03:52:33Z	Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors	JIH-HSIANG LEE; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:33Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:32Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:31Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:30Z	Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC	Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H.
臺大學術典藏	2022-02-14T07:10:41Z	Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors	Wu C.-W.; Yang C.-Y.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏	2022-02-14T07:10:40Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-14T07:10:39Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.
臺大學術典藏	2022-02-14T07:10:38Z	Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer	Lin C.-Y.; Huang K.-Y.; Lin Y.-C.; Yang S.-C.; Chung W.-C.; YIH-LEONG CHANG; Shih J.-Y.; Ho C.-C.; Lin C.-A.; Shih C.-C.; Chang Y.-H.; Kao S.-H.; Yang P.-C.
臺大學術典藏	2022-01-22T00:04:55Z	Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer	Chang, L. K.; Kuo, Y. W.; Wu, S. G.; Chung, K. P.; Shih, J. Y.
臺大學術典藏	2022-01-14T03:59:36Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	JO-PAI CHEN; Lo Y.; Yu C.-J.; Hsu C.; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2022-01-08T04:31:30Z	Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma	Gow C.-H.; MIN-SHU HSIEH; Liu Y.-N.; Lee Y.-H.; Shih J.-Y.
國立成功大學	2022	miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts	Chang, W.-T.;Shih, J.-Y.;Lin, Y.-W.;Huang, T.-L.;Chen, Z.-C.;Chen, Chen C.-L.;Chu, J.-S.;Liu, P.Y.
國立成功大學	2022	An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline	Chang, W.-T.;Liu, C.-F.;Feng, Y.-H.;Liao, C.-T.;Wang, J.-J.;Chen, Z.-C.;Lee, H.-C.;Shih, J.-Y.
國立成功大學	2022	Comparison of Surgical or Medical Castration-Related Cardiotoxicity in Patients with Prostate Cancer	Kan, W.-C.;Hsieh, K.-L.;Chen, Y.-C.;Ho, C.H.;Hong, C.-S.;Chiang, Chiang C.-Y.;Wu, N.-C.;Chen, M.;Shih, J.-Y.;Chen, Z.-C.;Chang, W.-T.

顯示項目 141-190 / 1137 (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52805553 線上人數 : 597 教育部委託研究計畫計畫執行:國立臺灣大學圖書館